COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=48907

Dewei Zhao

zhaodewei2016@163.com

2020-02-01

Recruiting

RCT

Randomized

Parallel

Open label

multi-center

Treatment

1. 2019-nCoV infected patients treated at Affiliated Zhongshan Hospital of Dalian University and Zhongnan Hospital of Wuhan University from January 2020 to December 2020 2. nCoV nucleic acid positive, 3. Aged >=18 years, 4. Patients understand the purpose of the trial, voluntarily sign informed consent, and agree to complete the rectification research process.

1. Those with allergies, 2. Patients with a history of severe cardio-cerebral vascular disease, diabetes, mental and neurological diseases, severe liver and renal insufficiency, 3. History of hip or knee trauma or surgery, 4. Patients who abuse drugs, 5. Those who are in the acute phase of chronic diseases, 6. Patients with other malignant diseases and a survival time of less than 12 months, 7. pregnancy,lactating women, 8. Poor compliance and unable to follow up on time, 9. Participants in clinical trials of other drugs or devices within the past 3 months.

3

Affiliated Zhongshan Hospital of Dalian University

18

100

China

No restriction on type of patients

0: No restriction on type of patients

45

CT of lung;CT and MRI of hip;

| Declared number of arm (3.0) differs from found arms (4.0)

Phase 0

[{"arm_notes": "", "treatment_id": 798, "treatment_name": "Methylprednisolone", "treatment_type": "Corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1633, "treatment_name": "M1 suppression therapy+methylprednisolone", "treatment_type": "Others pharmacological treatment+corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]